were prospectively enrolled. 100 patients who dropped out for medical reasons were excluded, resulting in 924 patients with acute coronary syndrome (ACS, n=388), elective percutaneous coronary intervention (elective PCI, n=129) or coronary artery bypass graft (CABG, n=407). Drop-out was defined as attending 50% of the training program, which has a maximum of 45 sessions, and the clinical profile of patients who dropped out was analyzed. A combined endpoint of all-cause mortality and rehospitalisation for a coronary event, cerebrovascular accident or heart failure (HF) was used to specify event-free survival. Differences in clinical characteristics were assessed according to event-free survival at 3 years after start of CR. Parameters with an overall significance value p<0.10 were entered in a multivariate Cox regression analysis. Results: 15% of CAD patients had a cardiovascular event or deceased during a median followup period of 33 months [24,51] after start of CR. Patients attended 36AE12 training sessions, with 18% dropping out in the first half of CR. Patients who dropped out early had more often COPD (p=0.049) and peripheral arterial disease (p=0.011) and were more smokers (p=0.025). They were also more frequently singles (p=0.07), more dependent on other to get to CR (p=0.026) and reported more anxiety-related problems (p=0.081). Analysis according to event-free survival at 3 years after start of CR revealed the following differences: drop-out (p=0.002), the primary indication for CR (p<0.001) and parameters associated with HF such as a prior history of HF (p=0.044), the use of ACE inhibitors (p=0.061) and left ventricular function (p=0.016). In a multivariate Cox regression analysis (n=842) with the abovementioned parameters, patients who withdrew prematurely had almost twice a higher risk for a cardiovascular event or death (HR 1.89 [1.26-2.83], p=0.002) than those who attended more than half of the program. Besides drop-out, both ACS and elective PCI as primary indication for CR was associated with an adverse outcome as compared to CABG (ACS 2.49[1.56-3.99]; PCI 2.51 [1.42-4.43]; all p<0.001) and also a prior history of HF remained negatively associated with event-free survival (3.75 [1.26-11.15; p=0.017). Conclusion: Drop-out for non-medical reasons is independently associated with an adverse outcome in CAD, with a higher event rate for the combined end-point of mortality and rehospitalisation among those patients who withdrew prematurely from CR. Therefore, underlying factors for drop-out should gain more attention in future research and should be taken into account when organizing CR in order to increase adherence to rehabilitation. Abstract number:388 389 Predictors of major adverse cardiovascular events after cardiac rehabilitation: a long-term follow-up study
Topic: Cardiac rehabilitation Background: Cardiac rehabilitation (CR) is a model of care proven to reduce mortality and morbidity in patients (pts) with coronary artery disease, however the mean follow-up after CR reported in literature is 12 months. Purpose: We analysed the occurrence of major adverse cardiovascular events (MACE) identifying predictors of MACE in pts with a long follow-up after CR. Methods: From 2009 to 2010, all pts discharged after STEMI, N-STEMI, coronary artery bypass graft (CABG) or elective percutaneous transluminal coronary angioplasty (PTCA) were referred to CR program. CR lasted 5.1 AE 4 months. The incidence of MACE (defined as death and hospitalization for cardiovascular causes) was assessed during a mean follow-up of 75 AE 8 months after CR. Results. We enrolled 839 pts (mean age 69AE11 years), 27% of them were elderly (older than 75 years), 30% had STEMI, 19% NSTEMI, 29% were post CABG and 22% post PTCA. MACE involved 18% of subjects and occurred significantly in post PTCA (28%, p= 0,05), elderly (35%, p= 0.019), diabetics (25%, p= 0.002) and in pts with chronic renal failure (29%, p= 0.000) while, were low post CABG (19%, p= 0.002). Multivariate analysis identified chronic renal failure (hazard ratio [HR] 1.4; 95% confidence interval [CI]: 1.8 to 3.8; p= 0.000) as the strongest independent predictor of MACE, followed by diabetes (HR 1.6; 95% CI: 1.1 to 2.3; p= 0.005), while CABG was protective (HR 0.5; 95% CI: 0.3 to 0.8; p= 0.005).
Conclusions:
This study identified high-risk categories of MACE and chronic renal failure and diabetes such as predictors of MACE, while CABG is protective.
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Impact of cardiac rehabilitation on the obstructive sleep apnoea in the coronary artery disease D David Hupin 1 , V Pichot 1 , D Maudoux 1 , E Sforza 1 , JC Barthelemy 1 , F Roche 1 1 CHU Saint Etienne Hopital Nord, Saint Etienne, France Topic: Cardiac rehabilitation Background: Obstructive sleep apnoea (OSA) syndrome is improved by physical activity in the general population. This has not been demonstrated in patients with coronary artery disease (CAD). Objective: We aimed to determine a correlation between cardiac rehabilitation and OSA syndrome in CAD patients. Methods: CAD patients were included in cardiac rehabilitation programme of the University Hospital. Patients were classified according to the severity of OSA syndrome. The number of events per hour was reported as the apnoea-hypopnoea index (AHI) measured from the Holter ECG and Electrocardiogram-Derived Respiratory (EDR). An AHI less than 5 was considered normal. An AHI of 5-14 was mild, 15-29 was moderate and more than 30 events per hour characterized severe OSA. Cardiopulmonary exercise testing (CPET) and baroreflex (BRS) were performed to assess respectively VO2 max and autonomic nervous system (ANS) at the beginning and at the end of the cardiac rehabilitation. Results Out of the 105 CAD patients included (95 men and 10 women, mean 55.2 AE12.4 years), 100 had at least one cardiovascular risk factor (98%), 65% were asymptomatic for OSA syndrome and 51% had an ANS dysfunction. The reduction in AHI was significant in CAD patients with severe OSA syndrome (9,26 AE9,5, p<0.0001). This correlation was even stronger than VO2 max and BRS were improved (11,55 AE9,1, p<0.001 with a gain over 20% of VO2 max and BRS) at the end of the rehabilitation. Conclusion Severe OSA syndrome is improved by cardiac rehabilitation among CAD patients. Autonomic Nervous System regulation by physical activity might be key for alternative therapy for OSA syndrome.
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Home-based cardiac rehabilitation as an alternative to centre-based cardiac rehabilitation: Economic evaluation of the FIT@Home study rates and enhance long-term effectiveness. However, evidence on its relative cost-effectiveness compared to centre-based CR is scarce. Methods: We randomized 90 low to moderate risk patients entering CR to 3 months of either home-based training (HB) or centre-based training (CB). We conducted an economic evaluation by comparing healthcare and non-healthcare costs of both groups after one year, and a cost-utility analysis based on quality-adjusted-life-years (QALYs). Results: The QALYs calculated for both groups were similar (CB: 0.78AE0.08, HB: 0.77AE0.13, p=0.73). The costs for the CR programmes were similar between groups (CB: E336AE68, HB: E314AE68, p=0.13). Total healthcare costs for the HB group were E437 less than for the CB group, and total non-healthcare costs were E2,723 less for the HB group. However, these differences were not significant (p=0.39 and p=0.12 respectively). From a societal perspective, a non-significant difference of E3,160 per patient in favour of home-based CR was found (p=0.09) and the probability that it was more cost-effective varied between 97% and 75% (willingness-to-pay of E0 and E100,000 per QALY respectively). Discussion: Although we found no statistically significant differences in QALYs and costs between home-based CR and centre-based CR, almost all components in the economic evaluation were favourable for the home-based CR. For the accepted willingness-to-pay per QALY (E20,000-40,000), we conclude that home-based CR training appears to be more cost-effective than centre-based CR. Topic: Telemedicine Background: Cardiac rehabilitation (CR) increases quality of life and reduces morbidity and mortality in patients with coronary artery disease (CAD). However, CR participation is generally low due to both internal, patient-related barriers (e.g. age, gender, anxiety, depression, comorbidities) and external barriers (e.g. transport difficulties, lack of CR facilities outside office hours). Cardiac telerehabilitation (CTR) has been shown to be an effective alternative for traditional CR and may increase its accessibility. However, it is unknown which factors influence the uptake of CTR and which patients should be offered CTR as an addition or alternative to traditional CR. Purpose: To investigate which factors influence the uptake of a CTR programme for patients with CAD.
Methods: In this retrospective study, conducted from May 1st 2016 until October 14th 2016, patients entering CR because of CAD were asked to participate in the SmartCare-CAD randomised controlled trial. In this trial, a total of 300 patients will be randomised to centre-based CR (control group) or CTR (intervention group). In the intervention group, patients perform exercise training at home using wearable sensors and receive weekly feedback through video consultations by a physical therapist, based on sensor data the patient has uploaded to a web application. Patients who refused to participate in the trial entered routine centre-based CR and were asked to provide their reason for refusal. All patients entering CR or CTR underwent a routine baseline assessment. To identify factors influencing CTR uptake, we compared demographic, disease-specific and geographic factors between trial participants and non-participants. Results: From May 1st 2016 until October 14th 2016, 169 patients with CAD were asked to participate in the SmartCare-CAD trial. Of these, 57 (34%) gave informed consent and 112 (66%) refused to participate. The most frequently reported reasons for refusal were insufficient computer skills (33%), trial participation being too demanding (20%), preference for centre-based CR (18%) or insufficient confidence in CTR (13%). Among trial participants, there were more male patients (87% vs. 67%, P=0.007), patients were younger (mean age 58.6 vs. 65.4 years, P=0.001), were more often highly educated (54% vs. 11%, p<0.001) and had less comorbidities (mean Charlson Comorbidity Index 0.48 vs. 1.38, p<0.001).
Conclusions: Patients who were willing to participate in a CTR programme were more often male and highly educated, were younger and had less comorbidities. To increase uptake rates of CTR, and thus of CR in general, CTR programmes should be adjusted to better suit females, elderly patients, and patients with more comorbidities and lower educational levels.
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The 2 (VO2max) is paramount prior to ET for exercise prescription and safety. The six minute walk test (6MWT) is commonly used to assess the submaximal level of VO2max of patients undergoing CR. However, the accuracy of the 6MWT has been limited by shorter walking courses used in clinical practice due to space constraints. With a higher frequency of turns, this leads to shorter distances measured which could then underestimate an individual's VO2max. To address this limitation, the 2 minute step test (2MST) has been used as an alternative to the 6MWT to assess VO2max in healthy older adults (Rikli & Jones, 1999) . However, the reliability and validity of the 2MST in older adults attending CR post coronary revascularisation (CRV) is unknown.
Purpose: To investigate the reliability and validity of the 2MST in older adults post-CRV. Methods: A prospective study was undertaken in a single cardiac rehabilitation centre in Singapore over a time period of one month. Participants were recruited from the Tan Tock Seng Hospital Cardiology clinic via referrals from their attending cardiologists for CR after a coronary event. Two 2MSTs and one 6MWT were completed on the same day in a single and standardised testing session. The 2MST measurements were taken by two raters for each individual. The six minute walk distance (6MWD) and 2MST steps recorded by both raters were analysed to determine the relationship and agreement between measurements. Results: 31 participants completed all three tests (2MST, 6MWT, 2MST) within one single testing session. Strong positive correlations were found between steps achieved during the 2MSTs and the 6MWD (r= 0.87, 95% CI 0.82 to 0.91, p< 0.0001). Excellent inter-rater reliability were demonstrated between raters during the 2MSTs (ICC = 0.999 to 1.000, p<0.0001). Excellent relative test-retest reliability were demonstrated in both 2MSTs recorded by both raters (ICC = 0.927 to 0.934, p<0.0001). However, absolute test-retest reliability may have been limited by a learning effect between repeated 2MSTs as there was an increase in steps ranging from a mean (SD) of 7.48(9.80) to 7.74(10.4) steps achieved during the second 2MST compared to the first 2MST. Conclusion: This study has shown that the 2MST, a novel and innovative outcome measure in CR, has the potential to be used as an alternative to the 6MWT for assessing functional aerobic capacity in older adults post-CRV. However, a practice trial is recommended at baseline to account for a potential learning effect as demonstrated in this study.
